Biological mechanisms influencing prosthetic bypass graft patency: Possible targets for modern graft design

European Journal of Vascular and Endovascular Surgery

Volumn 43, Issue 1, 2012, Pages 66-72

  Scharn, D M ^a   Daamen, W F ^a   Van Kuppevelt, T H ^a   Van Der Vliet, J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Graft engineering; Graft patency; Infrainguinal prothetic bypass graft surgery; Intimal hyperplasia

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ARGATROBAN; CELIPROLOL; CLOPIDOGREL; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; FLAVOPIRIDOL; GENERIC DRUG; HEPARAN SULFATE; HEPARIN; ILOPROST; INTERLEUKIN 1; LEPIRUDIN; NITRIC OXIDE; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR A; PRAVASTATIN; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; RAMIPRIL; RAPAMYCIN; RESULIN; ROSUVASTATIN; SELEKTIN; SOMATOMEDIN A; THROMBIN; TICLOPIDINE; TRANSFORMING GROWTH FACTOR BETA; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTERY INTIMA PROLIFERATION; BYPASS SURGERY; DRUG APPROVAL; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME RELEASE; EXTRACELLULAR MATRIX; FOOD AND DRUG ADMINISTRATION; HUMAN; INFRAINGUINAL PROSTHETIC BYPASS GRAFT SURGERY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPERPLASIA; PROSTHESIS DESIGN; THROMBOSIS; VASCULAR PATENCY;

EID: 83655201308     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2011.09.009     Document Type: Review

References (51)

1. C.P. Twine, and A.D. McLain Graft type for femoro-popliteal bypass surgery Cochrane Database Syst Rev 12 2010 CD001487
2. G.A. Grode, R.D. Falb, and J.P. Crowley Biocompatible materials for use in the vascular system J Biomed Mater Res 6 2004 77 84
3. J.P. O'Leary, A. Tabuenca, and L.R. Capote The physiologic basis of surgery 2007 Lippincott Williams & Wilkins
4. Z. Jiang Mastery of vascular and endovascular surgery 2006 Lippincott Williams & Wilkins
5. M.G. Davies, and P.-O. Hagen Pathobiology of intimal hyperplasia Br J Surg 81 1994 1254 1269 (Pubitemid 24275140)
6. R. Vashisht, M. Sian, P.J. Franks, and M.K. O'Malley Long-term reduction of intimal hyperplasia by the selective alpha-1 adrenergic antagonist doxazosin Br J Surg 79 1992 1285 1288 (Pubitemid 23008378)
7. L.W. Kraiss, and A.W. Clowes Response of the arterial wall to injury and intimal hyperplasia. In: the basic science of vascular disease 1997 Futura Publ. Co. Inc p. 289-317
8. M.G. Davies, and P.-O. Hagen Pathophysiology of vein graft failure: a review Eur J Vasc Endovasc Surg 9 1995 7 18
9. M.P. Ombrellaro, S.L. Stevens, J. Sciarrotta, M.B. Freeman, and M.H. Goldman Effect of endoluminal PTFE graft placement on cell proliferation, PDGF secretion, and intimal hyperplasia J Surg Res 63 1996 110 114 (Pubitemid 26197183)
10. A. Algra, M.J. Tangelder, J.A. Lawson, and B.C. Eikelboom Interpretation of Dutch BOA trial. Dutch bypass Oral anticoagulants or Aspirin study group Lancet 355 2000 1186 1187
11. J.J. Belch, J. Dormandy CASPAR Writing Committee Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial J Vasc Surg 52 2010 825 833
12. G. Joseph, and C.P.J. Sharma Prostacyclin immobilized albuminated surfaces Biomed Mater Res 21 1987 937 945 (Pubitemid 17112698)
13. Y.B. Aldenhoff, F.H. van Der Veen, J. ter Woorst, J. Habets, L.A. Poole-Warren, and L.H. Koole Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface J Biomed Mater Res 54 2001 224 233
14. C. Devine, and C. McCollum Heparin-bonded dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial J Vasc Surg 40 2004 924 931 (Pubitemid 39535222)
15. J.S. Lindholt, B. Gottschalksen, N. Johannesen, D. Dueholm, H. Ravn, and E.D. Christensen The Scandinavian propaten(®) trial - 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - a randomised clinical controlled multi-centre trial Eur J Vasc Endovasc Surg 41 2011 668 673
16. M.W. Radomski, R.M. Palmer, and S. Moncada Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium Lancet 2 1987 1057 1058 (Pubitemid 17154788)
17. K.S. Bohl, and J.L. West Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation Biomaterials 21 2000 2273 2278
18. J.E. Barbato, B.S. Zuckerbraun, M. Overhaus, K.G. Raman, and E. Tzeng Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome Am J Physiol Heart Circ Physiol 289 2005 H228 H236
19. T. Naruko, A. Itoh, K. Haze, S. Ehara, H. Fukushima, and Y. Sugama C-Type natriuretic peptide and natriuretic peptide receptors are expressed by smooth muscle cells in the neointima after percutaneous coronary intervention Atherosclerosis 181 2005 241 250 (Pubitemid 41019604)
20. V. Lindner, D.A. Lappi, A. Baird, R.A. Majack, and M.A. Reidy Role of basic fibroblast growth factor in vascular lesion formation Circ Res 68 1991 106 113
21. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest; 89:507-11.
22. E. Camerer Unchecked thrombin is bad news for troubled arteries J Clin Invest 117 2007 1486 1489 (Pubitemid 46871333)
23. L. Mureebe, S.E. Turnquist, and D. Silver Inhibition of intimal hyperplasia by direct thrombin inhibitors in an animal vein bypass model Ann Vasc Surg 18 2004 147 150 (Pubitemid 38509645)
24. M.G. Davies, M.L. Klyachkin, L. Barber, E. Svendsen, and P.O. Hagen Ramipril and experimental vein graft intimal hyperplasia Angiology 46 1995 91 97
25. 1-adrenoceptor subtypes Circ Res 89 2001 815 822 (Pubitemid 34633853)
26. K. Hattori, D. Yamanouchi, H. Banno, M. Kobayashi, K. Yamamoto, and J. Kajikuri Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production J Vasc Surg 46 2007 116 123 (Pubitemid 46990765)
27. The EPISTENT investigators Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade Lancet 352 1998 87 92
28. Y.J. Hong, M.H. Jeong, W. Kim, S.Y. Lim, S.H. Lee, and S.N. Hong Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries Am J Cardiol 94 2004 1050 1054 (Pubitemid 39336443)
29. H.R. Lijnen, B. Hoef, F. Lupu, L. Moons, P. Carmeliet, and D. Collen Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes Arterioscler Thromb Vasc Biol 18 1998 1035 1045 (Pubitemid 28323587)
30. W.P. Fay, N. Garg, and M. Sunkar Vascular functions of the plasminogen activation system Arterioscler Thromb Vasc Biol 27 2007 1231 1237 (Pubitemid 46809410)
31. G.X. Shen Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders Int J Mol Med 1 1998 399 408
32. A. Kusch, S. Tkachuk, S. Lutter, H. Haller, R. Dietz, and M. Lipp Monocyte-expressed urokinase regulates human vascular smooth muscle cell migration in a coculture model Biol Chem 383 2002 217 221 (Pubitemid 34224044)
33. V. Lindner, and M.A. Reidy Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor Proc Natl Acad Sci U S A 88 1991 3739 3743 (Pubitemid 21916699)
34. A. Razuvaev, and B. Henderson The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signalling J Vasc Surg 46 2007 108 115 (Pubitemid 46990746)
35. M.B. Grant, T.J. Wargovich, E.A. Ellis, and S. Caballero Localization of Insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells a potential treatment for restenosis? Circulation 89 1994 1511 1517 (Pubitemid 24114225)
36. A. Takahashi, T. Taniguchi, Y. Ishikawa, and M. Yokoyama Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53 Circ Res 84 1999 543 550 (Pubitemid 29138591)
37. R. Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 126
38. J.E. Rectenwald, L.L. Moldawer, T.S. Huber, J.M. Seeger, and C.K. Ozaki Direct evidence for cytokine involvement in neointimal hyperplasia Circulation 102 2000 1697 1702
39. N.M.M. Pires, A. Schepers, B.L. van der Hoeven, M.R. de Vries, L.S.M. Boestena, and J.W. Jukema Histopathologic alterations following local delivery of dexamethasone to inhibit restenosis in murine arteries Cardiovasc Res 68 2005 415 424 (Pubitemid 41566561)
40. J.R. Waller, N.R. Brook, G.R. Bicknell, and M.L. Nicholson Differential effects of modern immunosuppressive agents on the development of intimal hyperplasia Transpl Int 17 2004 9 14 (Pubitemid 38197021)
41. S.O. Marx, T. Jayaraman, L.O. Go, and A.R. Marks Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells Circ Res 76 1995 412 417
42. J. Sun, S.O. Marx, H.J. Chen, M. Poon, A.R. Marks, and L.E. Rabbani Role for p27(Kip1) in vascular smooth muscle cell migration Circulation 103 2001 2967 2972 (Pubitemid 32578136)
43. R.L. Geary, A.W. Clowes, S. Lau, S. Vergel, D.C. Dale, and W.R. Osborne Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy Hum Gene Ther 1994 1211 1216
44. M.S. Conte, D.F. Bandyk, A.W. Clowes, G.L. Moneta, L. Seely, and T.J. Lorenz Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery J Vasc Surg 43 2006 742 751
45. H.J. Dardik A 30-year odyssey with the umbilical vein graft J Am Coll Surg 203 2006 582 583
46. J.I. Rotmans, J.M. Heyligers, E.S. Stroes, and G. Pasterkamp Endothelial progenitor cell-seeded grafts: rash and risky Can J Cardiol 22 2006 929 932 (Pubitemid 44596493)
47. J.L. West, and J.A. Hubbell Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing Proc Natl Acad Sci USA 93 1996 13188 13193 (Pubitemid 26382791)
48. P.B. Dobrin, F.N. Littooy, and E.D. Endean Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts Surgery 105 1989 393 400 (Pubitemid 19076428)
49. M.S. Lemson, J.H. Tordoir, M.J. Daemen, and P.J. Kitslaar Intimal hyperplasia in vascular grafts Eur J Vasc Endovasc Surg 19 2000 336 350 (Pubitemid 30232605)
50. J.M. Panneton, L.H. Hollier, and J.M. Hofer Multicenter randomized prospective trial comparing a pre-cuffed polytetrafluoroethylene graft to a vein cuffed polytetrafluoroethylene graft for infragenicular arterial bypass Ann Vasc Surg 18 2004 199 206 (Pubitemid 38509653)
51. F. Lundgren PTFE bypass to below-knee arteries: distal vein collar or not? a prospective randomised multicentre study Eur J Vasc Endovasc Surg 39 2010 747 754